Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular and biologic determinants of neoadjuvant chemotherapy of locoregional breast cancer.

Seminars in oncology - 1 Apr 1998

Bhalla K, Harris W B

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Apoptosis
Share to Cell Cycle
Share to Cell Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Docetaxel

Share to Paclitaxel

Share to Taxoids

Source

Identifiers

PMID: 9566203

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular and biologic determinants of neoadjuvant chemotherapy of locoregional breast cancer.PMID 9566203Read ↗

Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patientsSemantic proximity Read ↗

Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategiesSemantic proximity Read ↗

Breast Molecular Profiling and Radiotherapy Considerations.Semantic proximity Read ↗

Pharmacogenomics of breast cancer therapy: An updateSemantic proximity Read ↗

Predictive factors for response to neoadjuvant therapy in breast cancer.Semantic proximity Read ↗

Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer.Semantic proximity Read ↗

Molecular determinants as therapeutic targets in cancer chemotherapy: An updateSemantic proximity Read ↗

Clinical Implications of Transcriptomic Changes After Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerSemantic proximity Read ↗

The clonal architecture and tumour microenvironment of breast cancers are shaped by neoadjuvant chemotherapySemantic proximity Read ↗

Genomic Predictors of Outcome and Treatment Response in Breast CancerSemantic proximity Read ↗

New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survival.Semantic proximity Read ↗

Molecular prognostic indicators for breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.